跳至主要内容
临床试验/EUCTR2015-003618-26-DK
EUCTR2015-003618-26-DK进行中(未招募)1 期

A Multicenter, Follow-Up Study to Assess Long-Term Electrophysiologic and Clinical Outcomes in Subjects Previously Enrolled in Study 215ON201 - RENEWed

Biogen Idec Research Limited0 个研究点目标入组 80 人开始时间: 2016年1月12日最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Must have participated in Study 215ON201 and received at least 1 dose of BIIB033 or placebo, as per protocol, within 2 years (+ up to 12 months) from Day 1 of this study (2 years from Week 32 or projected Week 32 visit, if the subject did not complete all visits in Study 215ON201).
  • 2. Ability of the subject to understand the purpose and risks of the study and provide signed and dated informed consent and authorization to use confidential health information in accordance with national and local subject privacy regulations.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 80
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Not previously enrolled in Study 215ON201.
  • 2. Inability to comply with study requirements.
  • 3. Other unspecified reasons that, in the opinion of the Investigator or Biogen, make the subject unsuitable for enrolment.
  • 4. Subjects with recent kidney function, such as serum creatinine above upper limit of normal range, will not be allowed to receive administration of gadolinium (Gd) but will otherwise be allowed to participate in the study, including MRI assessments not requiring the use of Gd.
  • 5. Female subjects must have had a recent pregnancy test and must not be breastfeeding prior to MRI assessments with Gd.

研究者

相似试验

进行中(未招募)
1 期
A Follow-Up Study to Look at Long-Term Responses in Subjects who previously took part in Study 215ON201Acute Optic NeuritisMedDRA version: 19.0Level: PTClassification code 10030942Term: Optic neuritisSystem Organ Class: 10029205 - Nervous system disorders
EUCTR2015-003618-26-DEBiogen Idec Research Limited80
进行中(未招募)
1 期
A Follow-Up Study to Look at Long-Term Responses in Subjects who previously took part in Study 215ON201
EUCTR2015-003618-26-CZBiogen Idec Research Limited80
进行中(未招募)
1 期
A Follow-Up Study to Look at Long-Term Responses in Subjects who previously took part in Study 215ON201Acute Optic NeuritisMedDRA version: 18.1Level: PTClassification code 10030942Term: Optic neuritisSystem Organ Class: 10029205 - Nervous system disorders
EUCTR2015-003618-26-BEBiogen Idec Research Limited80
进行中(未招募)
1 期
A Follow-Up Study to Look at Long-Term Responses in Subjects who previously took part in Study 215ON201Acute Optic NeuritisMedDRA version: 18.0 Level: PT Classification code 10030942 Term: Optic neuritis System Organ Class: 10029205 - Nervous system disorders
EUCTR2015-003618-26-GBBiogen Idec Research Limited52
进行中(未招募)
1 期
A Follow-Up Study to Look at Long-Term Responses in Subjects who previously took part in Study 215ON201Acute Optic NeuritisMedDRA version: 19.0Level: PTClassification code 10030942Term: Optic neuritisSystem Organ Class: 10029205 - Nervous system disorders
EUCTR2015-003618-26-SEBiogen Idec Research Limited80